REG - EQT Fd Mngmt S.à r.l Oxford Biomedica PLC - Rule 2.8 Announcement

Oxford BioMedicaAnnouncement

25/02/2026 12:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260225:nRSY3935Ua&default-theme=true

RNS Number : 3935U  EQT Fund Management S.à r.l.  25 February 2026

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR
INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A
VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

 

THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.8 OF THE CITY CODE ON TAKEOVERS
AND MERGERS (THE "CODE")

FOR IMMEDIATE RELEASE

25 February 2026

No intention to make an offer for Oxford Biomedica plc

Further to the announcement on 14 January 2026 by Oxford Biomedica plc ("OXB")
that EQT X EUR SCSp and EQT X USD SCSp each represented by its manager
(gérant), EQT Fund Management S.à r.l. (collectively referred to as "EQT")
was considering a possible offer for OXB, EQT today confirms that it is not
intending to make an offer for OXB.

EQT is appreciative of the engagement with OXB's board of directors and
management team and would like to thank them for their time and consideration
of this potential transaction.

This announcement is made by EQT in accordance with Rule 2.8 of the Code. As a
result of this announcement, EQT will, together with any party acting in
concert with it, be bound by the restrictions in Rule 2.8 of Code.

Under Note 2 on Rule 2.8 of the Code, EQT, and any party acting in concert
with it, reserves the right to set the restrictions in Rule 2.8 aside in the
following circumstances:

a.   with the agreement of the board of OXB;

b.   if a third party announces a firm intention to make an offer for OXB;

c.   if OXB announces a Rule 9 waiver (see Note 1 of the Notes on
Dispensations from Rule 9) or a reverse takeover (as defined in the Code); or

d.   if there has been a material change of circumstances (as determined by
the Takeover Panel).

 

Media Enquiries for EQT:

FGS Global

Faeth Birch / Chris Ryall / Sophia Johnston

EQT-LON@fgsglobal.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  OUPUVUARNKUUUAR



            Copyright 2019 Regulatory News Service, all rights reserved